Stocks · Healthcare · Medical - Instruments & Supplies
Becton, Dickinson and Company BDX
$176.80 -0.71% Close, Oct 2, 2026 · NYSE · Market cap $48.72B
Low risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 11 quarters (average surprise over the last four: +10.0%).
- The shares trade at 53.3× trailing earnings, higher than 95% of the company's own readings over the past five years.
- Diluted EPS over the last four quarters was $3.32, down 40.3% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth19Very weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 26%
- EPS growth (TTM, YoY)Bottom 30%
- FCF growth (TTM, YoY)Bottom 43%
- Revenue growth, 3-year CAGRBottom 37%
- Revenue growth accelerationBottom 26%
Quality72Positive
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 27%
- Gross marginBottom 30%
- Operating marginTop 27%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Bottom 40%
- Net debt / EBITDA (lower is better)Bottom 19%
- Interest coverTop 30%
Value68Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 25%
- Free-cash-flow yieldTop 17%
- EBITDA / enterprise valueTop 20%
- Sales / enterprise valueTop 40%
- P/E vs own 5-year history (lower is better)Bottom 8%
Momentum65Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 47%
- 6-month returnTop 44%
- 1-year return vs S&P 500Top 45%
- Distance from 52-week highTop 12%
- Trend checklist (0–4)Top 39%
Revisions41Weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 38%
- Consecutive EPS beatsTop 5%
- Share of analysts rating BuyBottom 14%
- Upside to consensus price targetBottom 14%
Stability85Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 5%
- Maximum drawdown, 3 yearsTop 12%
- Beta vs S&P 500 (lower is better)Top 11%
- Net debt / EBITDA (lower is better)Bottom 19%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.4% | -2.6% | ↓ |
| EPS growth (YoY) | -24.6% | -40.3% | ↓ |
| Gross margin | 44.9% | 46.1% | ↑ |
| Operating margin | 11.7% | 9.8% | ↓ |
| FCF margin | 11.9% | 12.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -2.6% | 2.4% | ↓ | Bottom 26% |
| EPS growth (TTM, YoY) | -40.3% | -24.6% | ↓ | Bottom 30% |
| Gross margin | 46.1% | 44.9% | ↑ | Bottom 30% |
| Operating margin | 9.8% | 11.7% | ↓ | Top 27% |
| Net margin | 4.5% | 7.4% | ↓ | — |
| Free-cash-flow margin | 12.5% | 11.9% | ↑ | — |
| Return on invested capital | 3.7% | — | Top 27% | |
| Revenue growth, 3-year CAGR | 5.0% | — | Bottom 37% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -17.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.13×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 3.61%
- Net buyback yield (TTM)
- 5.13%
- Shareholder yield
- 8.75%
- Share count change, 1 year
- -4.7%
- Share count change, 3-year CAGR
- -1.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 11
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +10.0%
- Average 2-day reaction, last 8
- -0.6%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $186.88
- Target vs current price
- +5.7%
- Analysts with a rating
- 34
- Share rating Buy or Strong Buy
- 47%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +2.9% | +3.8% | +7.6% | +9.9% | — |
| May 7, 2026 | +4.3% | +5.9% | -0.4% | +3.3% | +17.6% |
| Feb 9, 2026 | +31.7% | -1.3% | +6.5% | +0.2% | -12.7% |
| Nov 6, 2025 | +1.0% | +0.6% | +8.9% | +9.9% | +17.1% |
| Aug 7, 2025 | +8.2% | +8.9% | +13.7% | +10.9% | +4.0% |
| May 1, 2025 | +2.1% | -18.1% | -19.3% | -16.1% | -11.7% |
| Feb 5, 2025 | +14.3% | +1.1% | -5.3% | -7.6% | -30.1% |
| Nov 7, 2024 | +1.1% | -5.4% | -3.7% | -7.4% | +2.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $3.23 | $3.14 | +2.9% | $4.98B |
| May 7, 2026 | $2.90 | $2.78 | +4.3% | $4.71B |
| Feb 9, 2026 | $2.91 | $2.21 | +31.7% | $4.49B |
| Nov 6, 2025 | $3.96 | $3.92 | +1.0% | $5.89B |
| Aug 7, 2025 | $3.68 | $3.40 | +8.2% | $5.51B |
| May 1, 2025 | $3.35 | $3.28 | +2.1% | $5.27B |
| Feb 5, 2025 | $3.43 | $3.00 | +14.3% | $5.17B |
| Nov 7, 2024 | $3.81 | $3.77 | +1.1% | $5.44B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 53.3× | 34.2× | 95th | Top 25% |
| P/E (forward) | 14.0× | — | — | — |
| EV / EBITDA | 16.6× | — | — | Top 20% |
| EV / Sales | 3.11× | — | — | Top 40% |
| Free-cash-flow yield | 5.35% | — | — | Top 17% |
| Earnings yield | 1.88% | — | — | Top 25% |
P/E over the past five years
Range 25.4× – 53.3× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +17.8%
- Earnings per share growth (TTM)
- -40.3%
- Change in P/E multiple
- +100.9%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 50
- 50-day average slope (20 days)
- +6.4%
- 200-day average slope (20 days)
- +1.8%
- Distance from 50-day average
- -1.8%
- Distance from 200-day average
- +8.8%
- RSI (14)
- 42.2
- Relative volume
- 1.03×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 26.1%
- Volatility vs own 5-year history
- 78th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.37
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -7.9%
- Maximum drawdown, 3 years
- -38.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jul 27, 2023 | May 6, 2025 | -41.8% | 445 days | Not yet recovered |
| Apr 8, 2022 | Nov 9, 2022 | -20.8% | 148 days | 174 days (Jul 24, 2023) |
| Jan 20, 2021 | Oct 11, 2021 | -10.4% | 183 days | 66 days (Jan 13, 2022) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $48.72B
- P/E (TTM)
- 53.3
- EPS, diluted (TTM)
- $3.32
- Revenue (TTM)
- $20.84B
- Dividend yield
- 2.38%
- 52-week range
- $127.59 – $193.07
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $19.13B | $18.87B | $19.37B | $20.18B | $21.84B |
| Gross profit | $8.63B | $8.48B | $8.17B | $9.13B | $9.92B |
| Operating income | $2.25B | $2.28B | $2.11B | $2.40B | $2.58B |
| Net income | $2.09B | $1.78B | $1.48B | $1.71B | $1.68B |
| EPS (diluted) | $6.85 | $5.88 | $4.94 | $5.86 | $5.83 |
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.44B | $5.17B | $5.27B | $5.51B | $5.89B | $5.25B | $4.71B | $4.98B |
| Net income | $400.0M | $303.0M | $308.0M | $574.0M | $493.0M | $382.0M | -$311.0M | $377.0M |
| EPS (diluted) | $1.45 | $1.04 | $1.07 | $2.00 | $1.72 | $1.34 | -$1.11 | $1.37 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $4.65B | $2.63B | $2.99B | $3.80B | $3.43B |
| Capital expenditure | -$1.23B | -$973.0M | -$874.0M | -$725.0M | -$760.0M |
| Free cash flow | $3.42B | $1.66B | $2.12B | $3.07B | $2.67B |
| Dividends paid | -$1.05B | -$1.08B | -$1.11B | -$1.10B | -$1.20B |
| Net share buybacks | -$1.75B | -$500.0M | $0 | -$500.0M | -$1.00B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $709.0M
- Total assets
- $50.73B
- Total liabilities
- $26.31B
- Total debt
- $16.81B
- Net debt
- $16.10B
- Shareholders’ equity
- $24.42B
As of Jun 30, 2026 (filed Aug 6, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 9, 2026 | $1.05 | Sep 30, 2026 |
| Jun 9, 2026 | $1.05 | Jun 30, 2026 |
| Mar 10, 2026 | $1.05 | Mar 31, 2026 |
| Dec 8, 2025 | $1.05 | Dec 31, 2025 |
| Sep 8, 2025 | $1.04 | Sep 30, 2025 |
| Jun 9, 2025 | $1.04 | Jun 30, 2025 |
| Mar 10, 2025 | $1.04 | Mar 31, 2025 |
| Dec 9, 2024 | $1.04 | Dec 31, 2024 |
Short interest
- Shares sold short
- 11,316,237
- Days to cover
- 7.19
- Change vs previous report
- +6.0%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Feb 10, 2026
- 159-for-125
- Apr 1, 2022
- 41-for-40
- Aug 21, 1998
- 2-for-1
- Aug 16, 1996
- 2-for-1
- Mar 1, 1993
- 2-for-1